ストックスクリーナーアプリを入手
0.2636
1.31%
0.0034
アフターアワーズ：
.27
0.0064
+2.43%
AEON Biopharma Inc. (AEON) 最新ニュース
Live AEON Biopharma, Inc. (AEON) Technical Analysis - Traders Union
AEON Biopharma (AEON) Ticks Up to $0.26 as Sub-$1 Micro-Cap Defends $0.25 SupportSkew Index - siam.in
$AEON Biopharma (AEON.US)$ following choch - Moomoo
AEON Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Stock SlidesEPS Guidance Update - careplusvn.com
AEON Biopharma, Inc. Stock Price Today | AEON Live Chart & News - Traders Union
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$AEON Biopharma (AEON.US)$ 1 choch, 2 choch, last major choch almost ✔️ and consolidation over. - Moomoo
$AEON Biopharma (AEON.US)$ - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Biotech Pre-Market Movers: TNON, AEON Surge; COO, CDT Slide - RTTNews
$AEON Biopharma (AEON.US)$ interesting. got it marked from 2025 not sure why lmao - Moomoo
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
The rocket is about to launch 😘 - Moomoo
Laidlaw initiates Aeon Biopharma stock coverage with buy rating By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
$AEON Biopharma (AEON.US)$ goshhh.. 😅 - Moomoo
Aeon Claims Drug Holds Up Against Botox in Stress Test - Orange County Business Journal
AEON Biopharma, Inc. Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of Abp-450 to Botox - marketscreener.com
AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX - marketscreener.com
BOTOX and ABP-450 each fell to about half strength by day 14 - Stock Titan
Laidlaw initiates Aeon Biopharma stock coverage with buy rating - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference - The Manila Times
AEON Biopharma to Host Investor Meetings at Lake Street Capital Markets’ 10th Annual BIG10 Conference - quiverquant.com
AEON Biopharma (AEON) Surges 6.91% to $0.31, Nears Key Resistance at $0.33Low Volatility Picks - dars.gov.et
AEON Q2 2026 Earnings: Clinical-Stage Biotech Delivers Narrow EPS BeatFinancial Data - dars.gov.et
Insider Purchase: 10% Owner at $AEON Buys 1,150,000 Shares - Moomoo
AEON Biopharma names Paul Lee as acting chief regulatory officer By Investing.com - Investing.com Nigeria
AEON Biopharma names Paul Lee as acting chief regulatory officer - Investing.com
AEON (AEON) Price: Moves 0.52% Down to $0.19 in Latest Trading; Price Levels: Price Remains Between $0.18 Support and $0.20 Resistance under the Current SnapshotMcClellan Oscillator - careplusvn.com
Aeon Biopharma director Timothy Lynch buys $243,455 in stock By Investing.com - Investing.com India
Aeon Biopharma director Timothy Lynch buys $243,455 in stock - Investing.com
Timothy Lynch (NASDAQ: AEON) owns 13% and holds blocked warrants - Stock Titan
AEON Reports New Data on Botox Biosimilar - Orange County Business Journal
Lake Street Maintains AEON Biopharma(AEON.US) With Buy Rating, Maintains Target Price $1 - Moomoo
AEON Flat on BOTOX Developments - Baystreet.ca
META_TITLE_QUOTE - Yahoo Finance
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX® - The Manila Times
AEON Biopharma (AEON) Steadies at $0.28 as Key Support HoldsVolume Gap - vinanet.vn
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution - Investing.com
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution By Investing.com - Investing.com UK
AEON Biopharma (AEON) Holds Above $0.27 Support as Shares Edge Up 1.66%Extension Target - vinanet.vn
AEON Q4 2025 Earnings: Wider-than-Expected Loss of -$0.42 per Share as Revenue Remains Absent - vinanet.vn
H.C. Wainwright Maintains AEON Biopharma(AEON.US) With Buy Rating, Cuts Target Price to $1.2 - Moomoo
AEON Biopharma Q2 EPS $(0.02) beats $(0.12) estimate - scanx.trade
AEON Biopharma Reports Q2 Results, Advances ABP-450 Program - TipRanks
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma Q2 net loss narrows on warrant gain; cash runway extended - TradingView
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
AEON BIOPHARMA INC Q2 EBIT USD -5.919 MILLION - Moomoo
AEON Biopharma (AEON) Slips to $0.28 as Stock Tests Key Support ZoneRisk Reversal - careplusvn.com
Aeon Biopharma Inc (AEON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards - The Manila Times
Aeon Biopharma Inc (AEON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AEON Biopharma Regains NYSE American Listing Compliance - TipRanks
AEON Biopharma Regains NYSE American Compliance After Completing Public Offering - Quiver Quantitative
AEON Biopharma (NYSE American: AEON) lifts .BC indicator after $13.6M equity raise - Stock Titan
AEON Q4 2025 Earnings: Wider Loss of -$0.42 Per Share Overshadowed by 14.81% Stock SurgePerformance Review - dars.gov.et
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):